Pharmaceutical intermediates are fine chemical products in the production process from pharmaceutical chemical raw materials to bulk drugs or drugs. The synthesis of chemical drugs depends on high-quality pharmaceutical intermediates. This chemical, which does not require a drug production license, can be produced in ordinary chemical plants and can be used in the synthesis of drugs as long as it reaches certain grades.

Intermediates and additives are common in our daily life, for example, vitamins, disperse dyes, bleaches and emulsifiers are collectively called Intermediates and additives. Today, this article focuses on introducing what intermediates are and what are the differences between them and API.

Pharmaceutical intermediates refer to the chemical raw materials or chemical products used in the pharmaceutical synthesis process. From the perspective of the development history of China's pharmaceutical intermediates industry, after nearly 30 years of development, pharmaceutical intermediates have developed from a small branch of the chemical industry into an emerging industry with an output value of billions of yuan, and the market competition has become increasingly fierce.

About Favipiravir Chemical name:Favipiravir; 6-fluoro-3-hydroxypyrazine-2-carboxamide.Molecular formula: C24H29N5O3structural formula：

What is an active pharmaceutical ingredient (API in pharma)? In the pharmaceutical industry, a widely used term is ‘API’, which means Active Pharmaceutical Ingredient and refers to the ingredients or active pharmaceutical substances that can eventually be converted into a medicine.

A review of six Phase 3 studies shows that tofacitinib is more effective for rheumatoid arthritis (RA) treatment than regimens including placebo and a disease modifying anti-rheumatic drug or methotrexate (MTX) as monotherapy or in combination therapy. The efficacy of tofacitinib was similar in pati

Baloxavir marboxilGeneric Name: baloxavir marboxil (ba LOX a vir mar BOX il)Brand Name: XofluzaWhat is baloxavir marboxil?Baloxavir marboxil is used to treat flu symptoms caused by influenza virus in people who have had symptoms for no more than 48 hours. Baloxavir marboxil will not treat the common

On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK in

RelugolixRelugolix (also known as Relumina, TAK-385, or RVT-601) is a gonadotropin-releasing hormone (GnRH) receptor antagonist being developed and tested by Myovant Sciences. This oral once-daily medicine is intended to treat endometriosis, as well as uterine fibroids and hormone-sensitive prostate